Related Experiment Video
Updated: Aug 5, 2026

08:27
Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
AI-Guided Home-Based Therapy for Convergence Insufficiency: A Comparative Feasibility Study with Pencil Push-Ups
Ahmad Khatib1, Shmuel Raz1, Elad Shvartz2,3
1Department of Information Systems, University of Haifa, Haifa 3498838, Israel.
Bioengineering (Basel, Switzerland)
|July 28, 2026
Summary
A new AI smartphone app for convergence insufficiency (CI) showed higher adherence and improved NPC compared to traditional pencil push-ups. This digital approach offers a promising, feasible home-based therapy for CI management.
Area of Science:
- Ophthalmology
- Vision Science
- Digital Health
Background:
- Convergence insufficiency (CI) is a common visual disorder causing eye strain and headaches.
- Traditional pencil push-ups (PPU) for CI may have limited effectiveness due to inconsistent adherence.
- MobileS, an AI app, offers guided digital push-ups with real-time feedback and monitoring for CI treatment.
Purpose of the Study:
- Evaluate the feasibility of the MobileS app for home-based CI therapy.
- Compare adherence rates between the MobileS app and conventional PPU.
- Assess preliminary clinical signals, including near point of convergence (NPC) and symptom severity, for MobileS compared to PPU.
Main Methods:
- Twenty-five participants with CI were randomized into an App group (n=12) or PPU group (n=13) for 8 weeks of home therapy.
- Near point of convergence (NPC) was measured at baseline, midpoint, and endpoint.
- Adherence was automatically recorded by the app or manually logged; symptom severity was assessed using the CISS.
Main Results:
- The App group demonstrated a statistically significant improvement in NPC (p=0.007), while the PPU group did not.
- Recorded adherence was significantly higher in the App group (90.1%) compared to the PPU group (75.4%) (p=0.0069).
- The App group experienced a significant reduction in symptom severity (p=0.049).
Conclusions:
- The MobileS app is a feasible tool for home-based CI management.
- MobileS demonstrated higher adherence and preliminary improvements in NPC compared to PPU.
- Larger studies are required to confirm efficacy, especially for symptom reduction, and to guide teleophthalmology implementation.
